Hair loss pathology identified in pityriasis versicolor lesions

May 23, 2012
Hair loss pathology identified in pityriasis versicolor lesions
Patients with pityriasis versicolor lesions may experience hair thinning and/or loss within the lesion, according to a study published online May 10 in the Journal of the American Academy of Dermatology.

(HealthDay) -- Patients with pityriasis versicolor (PV) lesions may experience hair thinning and/or loss within the lesion, according to a study published online May 10 in the Journal of the American Academy of Dermatology.

Wedad Z. Mostafa, M.D., of the Kasr Al Ainy School of Medicine at Cairo University, and colleagues examined 39 patients with PV during a period of 11 months. Skin biopsies were taken from both lesional and nonlesional skin to verify and explore the underlying pathology of hair loss in PV.

The researchers found that hair loss and/or thinning within PV lesions most commonly occurred on the forearms, abdomen, neck, and beard area (in males only), and was seen in 61.5 percent of patients. In 46 percent of PV lesions there was evidence of basal hydropic degeneration, follicular degeneration, miniaturization, atrophy, plugging, and/or hair shaft absence, compared with only 20.5 percent of nonlesional biopsy samples. Hair loss within the PV lesions was associated with Malassezia organism presence within the and/or stratum corneum.

"The current study describes for the first time to our knowledge hair thinning or loss in PV and provides evidence on the underlying in the hair follicles," the authors write.

Explore further: Some hair professionals report looking for skin cancer lesions on customers' scalp, neck and face

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Some hair professionals report looking for skin cancer lesions on customers' scalp, neck and face

October 17, 2011
In a survey of hair professionals, some reported that they look at customers' face, scalp and neck for suspicious skin lesions, according to a report in the October issue of Archives of Dermatology.

Research identifies inhibitor causing male pattern baldness and target for hair-loss treatments

March 21, 2012
Researchers from the Perelman School of Medicine at the University of Pennsylvania have identified an abnormal amount a protein called Prostaglandin D2 in the bald scalp of men with male pattern baldness, a discovery that ...

Recommended for you

Study ends debate over role of steroids in treating septic shock

January 19, 2018
The results from the largest ever study of septic shock could improve treatment for critically ill patients and save health systems worldwide hundreds of millions of dollars each year.

New approach could help curtail hospitalizations due to influenza infection

January 18, 2018
More than 700,000 Americans were hospitalized due to illnesses associated with the seasonal flu during the 2014-15 flu season, according to federal estimates. A radical new approach to vaccine development at UCLA may help ...

Zika virus damages placenta, which may explain malformed babies

January 18, 2018
Though the Zika virus is widely known for a recent outbreak that caused children to be born with microencephaly, or having a small head, and other malformations, scientists have struggled to explain how the virus affects ...

Certain flu virus mutations may compensate for fitness costs of other mutations

January 18, 2018
Seasonal flu viruses continually undergo mutations that help them evade the human immune system, but some of these mutations can reduce a virus's potency. According to new research published in PLOS Pathogens, certain mutations ...

Study reveals how MRSA infection compromises lymphatic function

January 17, 2018
Infections of the skin or other soft tissues with the hard-to-treat MRSA (methicillin-resistant Staphylococcus aureus) bacteria appear to permanently compromise the lymphatic system, which is crucial to immune system function. ...

Fresh approach to tuberculosis vaccine offers better protection

January 17, 2018
A unique platform that resulted in a promising HIV vaccine has also led to a new, highly effective vaccine against tuberculosis that is moving toward testing in humans.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.